Skip to main content

Table 1 Clinical characteristics and lipids levels of patients before treatment

From: Endothelial lipase genetic polymorphisms and the lipid-lowering response in patients with coronary artery disease on rosuvastatin

Parameters

n = 121

Age (years)

62.17 ± 9.71

Male [n(%)]

87 (71.90%)

Smoking [n(%)]

42 (34.71%)

EH [n(%)]

87 (71.90%)

DM [n(%)]

30 (24.79%)

TCa (mmol/l)

4.59 ± 0.96

TG (mmol/l)

2.01 ± 1.18

HDL-C (mmol/l)

1.07 ± 0.30

LDL-C (mmol/l)

2.77 ± 0.83

2037 T/C (rs3744843)

 TT [n(%)]

68 (56.20%)

 CT [n(%)]

47 (38.84%)

 CC [n(%)]

6 (4.96%)

2237 G/A (rs3744841)

 GG [n(%)]

46 (38.02%)

 GA [n(%)]

60 (49.59%)

 AA [n(%)]

15 (12.40%)

  1. N number, EH essential hypertension, DM diabetes mellitus, TC a total cholesterol, TG triglyceride, HDL-C high density lipoprotein cholesterol, LDL-C low density lipoprotein cholesterol; Continuous variables were represented as means ± SD